| Term 
 | Definition 
 
        | synthetic, wide antibacterial spectrum, favorable pharmacokinetic properties, few AE, but emerging resistance. TX for UTIs |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd gen fluoroquinolone- PO/IV. prototype |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 4th gen fluoroquinolone- fatal hepatotoxicity- withdrawn from US market. |  | 
        |  | 
        
        | Term 
 
        | Diarrhea, Nausea, HA, dizziness, light-headed, crystalluria, rash, articular cartilage erosion.  CI- preggo, lactation, renal damage. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | UTI, prostatitis; resp tract infection; STD (gonorrhea, not syphilis); GI infections; bone, joint, & soft tissue infections; multidrug resistant TB & atypical mycobacterial infections |  | Definition 
 
        | Therapeutic uses fluoroquinolones |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Urinary tract antiseptic- breaks down formaldehyde which kills the bugs. TX chronic cystitis |  | 
        |  | 
        
        | Term 
 
        | Nitrofurantoin (macrobid) |  | Definition 
 
        | Urinary tract antiseptic- less common, narrow spectrum, toxic. Bacteriostatic. turns urine brown. |  | 
        |  | 
        
        | Term 
 
        | GI disturbances, acute pneumonitis, hemolytic anemia, agranulocytosis, hepatotoxic, pancreatitis |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antimcobacterial- TX against Tb. bactericidal against extracellular and intracellular growing bacilli. interferes with biosynthesis of cell wall mycolic acids |  | 
        |  | 
        
        | Term 
 
        | Peripheral neuritis, hepatotoxicity, potential for seizures, inhibit metabolism phenytoin, hypersensitivity- rash, fever |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antimycobacterial- bactericidal against extracellular cavitary bacili & organisms in closed lesions. inhibits bacteral DNA-dependent RNA polymerase |  | 
        |  | 
        
        | Term 
 
        | hypersensitivity, epigastric distress, NVD, cramps, fever; hepatotoxicity & jaundice, turns saliva, tears, urin, sweat orange/red color. Drug interactions- induces CYP450 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antimycobacterial- bacteriocidal. absorbed orally, distributed throughout body & CSF.  excreted by kidney. |  | 
        |  | 
        
        | Term 
 
        | Hepatotoxic, hyperuricemic, ocassional GI |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antimycobacterial- bacteriostatic. used in combination. oral, distributed through & CSF. kidney excretion |  | 
        |  | 
        
        | Term 
 
        | Optic neuritis, urate retention & gouty attacks |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antimycobacteral- bacteriocidal to extracellular TB. problem with resistance, use in combo. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Leprosy- sulfonamide related PABA antagonist. bacteriostatic. |  | 
        |  |